Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427)
Hong Kong · Delayed Price · Currency is HKD 4.300
-0.040 (-0.92%)
At close: Jun 1, 2026
HKG:2427 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -29.72 | 17.2 | 27.57 | 17.94 | 22.94 |
Depreciation & Amortization | 14.44 | 7.04 | 5.98 | 4.45 | 3.59 |
Other Amortization | 1.29 | 0.24 | 0.03 | 0.84 | 0.83 |
Loss (Gain) From Sale of Assets | 10.23 | 5.52 | 1.49 | - | - |
Asset Writedown & Restructuring Costs | 5.07 | - | - | - | - |
Stock-Based Compensation | 1.73 | 1.4 | - | - | 2.12 |
Provision & Write-off of Bad Debts | 3.83 | 3.2 | 4.28 | 0.2 | -0.07 |
Other Operating Activities | -2.32 | -1.84 | -6.55 | 4.26 | -3.99 |
Change in Accounts Receivable | 7.07 | -57.21 | 30.5 | -17.9 | -40.55 |
Change in Inventory | 7.01 | -3.48 | 4.51 | -2.83 | 9.06 |
Change in Accounts Payable | 0.68 | -0.82 | -0.91 | -12.52 | 12.03 |
Change in Unearned Revenue | -0.47 | -0.09 | -0.55 | 0.32 | -2.37 |
Change in Other Net Operating Assets | -8.49 | 58.47 | -57.49 | 14.55 | -0.49 |
Operating Cash Flow | 10.35 | 29.62 | 8.85 | 9.32 | 3.09 |
Operating Cash Flow Growth | -65.05% | 234.79% | -5.01% | 201.16% | -89.02% |
Capital Expenditures | -19.5 | -35.19 | -7.3 | -9.33 | -7.81 |
Sale of Property, Plant & Equipment | 8.2 | 1.71 | - | - | - |
Sale (Purchase) of Intangibles | - | -3.77 | - | - | -0.05 |
Investing Cash Flow | -11.31 | -37.25 | -7.3 | -9.33 | -7.86 |
Short-Term Debt Issued | 7.86 | 12.71 | 27.77 | 31.11 | 26.39 |
Total Debt Issued | 7.86 | 12.71 | 27.77 | 31.11 | 26.39 |
Short-Term Debt Repaid | -12.81 | -16.15 | -33.53 | -23.78 | -45.77 |
Long-Term Debt Repaid | -0.38 | -0.32 | -0.26 | -0.08 | -0.08 |
Total Debt Repaid | -13.18 | -16.46 | -33.79 | -23.86 | -45.85 |
Net Debt Issued (Repaid) | -5.32 | -3.75 | -6.02 | 7.25 | -19.46 |
Issuance of Common Stock | - | - | 82.4 | 9.25 | 14.39 |
Repurchase of Common Stock | - | -10.47 | - | - | - |
Common Dividends Paid | - | -18.19 | -18.31 | - | - |
Other Financing Activities | -0.02 | -0.08 | -20.64 | -7.35 | 24.54 |
Financing Cash Flow | -5.34 | -32.5 | 37.44 | 9.15 | 19.48 |
Net Cash Flow | -6.29 | -40.12 | 38.98 | 9.13 | 14.71 |
Free Cash Flow | -9.15 | -5.56 | 1.54 | -0.01 | -4.72 |
Free Cash Flow Margin | -10.35% | -3.57% | 0.99% | -0.01% | -2.23% |
Free Cash Flow Per Share | -0.01 | -0.01 | 0.00 | - | -0.01 |
Cash Interest Paid | 0.52 | 0.71 | 0.83 | 1.02 | 0.58 |
Cash Income Tax Paid | 0.67 | 8.09 | 7.9 | 7.76 | 14.13 |
Levered Free Cash Flow | 9.58 | -24.07 | 62.56 | -66.96 | -3.21 |
Unlevered Free Cash Flow | 9.91 | -23.62 | 63.09 | -66.32 | -2.83 |
Change in Working Capital | 5.8 | -3.14 | -23.95 | -18.38 | -22.31 |